AOTI, Inc. (AOTI) AI Stock Analysis

• Market Cap: £36.16M
• Dividend Yield: N/A
• Average Volume (3M): 36.39K
• Price to Earnings (P/E): 171.8
• Beta (1Y): 0.19
• Revenue Growth: 29.20%
• EPS Growth: 78.32%
• Country: UK
• Employees: 85
• Sector: General
• Sector Strength: N/A
• Industry: Medical - Specialties
• EPS (TTM): 0.00
• Shares Outstanding: 106,359,160
• 10 Day Avg. Volume: 30,736
• 30 Day Avg. Volume: 36,392
• PEG Ratio: -0.28
• Price to Book (P/B): 8.47
• Price to Sales (P/S): 2.53
• P/FCF Ratio: -18.81
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): 0.02
• Revenue Forecast (FY): £74.60M

• Rating: 54 Neutral
• Price Target: 43.00 p ▲(56.36% Upside)
• Action: Reiterated Date: 01/15/26
• Date: Action: Reiterated 01/15/26

The score is primarily constrained by ongoing losses and weak cash flow sustainability despite strong revenue growth and improved margins. Technicals are supportive but show signs of being stretched, and valuation is pressured by negative earnings with no dividend support.

Positive Factors

Revenue growth and gross margin expansion

Sustained top-line growth combined with a dramatic gross margin improvement implies stronger product-market fit and scalable unit economics. Over 2–6 months this supports reinvestment in R&D and sales, improving competitive positioning and long-term gross-profit resilience.

Improved capital structure

A move to positive equity and a materially higher equity ratio materially reduces solvency risk and interest burden. This lasting improvement enhances financial flexibility to fund growth initiatives, absorb shocks, and pursue partnerships without immediate refinancing pressure.

Recurring revenue and strategic partnerships

Recurring service and maintenance contracts create predictable revenue and higher customer retention, while strategic partnerships expand distribution and co-development capabilities. These durable revenue characteristics support more stable cash flows and scaled market penetration.

Negative Factors

Persistent unprofitability

Ongoing net losses erode retained capital and require external funding to sustain growth. Over months this limits the firm's ability to self-finance expansion, increases dilution or debt risk, and challenges the transition from margin improvements to consistent net profitability.

Weak cash flow conversion

Negative operating and free cash flow indicate the business struggles to convert revenues into liquid resources. This structural cash conversion weakness heightens liquidity risk, forces reliance on external financing, and constrains sustainable investment in product and sales capacity.

Reliance on financing and leverage history

Although leverage fell in 2024, a history of high liabilities and recent dependence on financing imply ongoing funding risk. In adverse conditions this can lead to costly refinancing, restrictive covenants, or equity dilution, limiting strategic flexibility over the medium term.

AOTI, Inc. Business Overview & Revenue Model

Company Description

AOTI, Inc. engages in the development and sale of medical solutions for chronic wounds. Its products include the Topical Wound Oxygen (TWO2) Therapy and the NEXA NPWT (negative pressure wound therapy) System. The company was founded by Michael Stephen Griffiths in 2006 and is headquartered in Oceanside, CA.

How the Company Makes Money

AOTI generates revenue through multiple streams, including the sale of its proprietary optical systems and imaging software to healthcare providers, research institutions, and industrial clients. The company also engages in ongoing service contracts and maintenance agreements, which provide a steady income from existing customers. Additionally, AOTI has established strategic partnerships with key players in the healthcare and technology sectors, allowing for collaborative product development and expanded market reach. These partnerships contribute significantly to its earnings by creating synergies and enhancing its competitive position in the optical technology market.

AOTI, Inc. Financial Statement Overview

Summary

Strong revenue growth and a major improvement in gross margin, with some operational efficiency gains in 2024. However, the company remains unprofitable with persistent net losses, and cash flow quality is weak with negative operating and free cash flow, increasing liquidity risk despite an improving balance sheet.

Income Statement

AOTI, Inc. has shown significant revenue growth from 2021 to 2024, with a remarkable increase in gross profit margin from 5.1% in 2021 to 88.0% in 2024. However, the company remains unprofitable, with net profit margins consistently negative. EBIT and EBITDA margins improved in 2024, indicating better operational efficiency, but the persistence of net losses suggests underlying challenges in achieving profitability.

Balance Sheet

The balance sheet shows improvement in stockholders' equity, turning positive from a negative position in 2023. The debt-to-equity ratio decreased substantially in 2024, suggesting reduced leverage, but remains a risk factor given the company's history of high liabilities relative to equity. The equity ratio improved to 44.1% in 2024, reflecting a stronger capital structure.

Cash Flow

AOTI, Inc. has experienced volatile cash flows, with negative operating and free cash flows in 2024, despite an increase in financing activities. The company struggles to convert net income into positive cash flows, as seen in the negative operating cash flow to net income ratio, indicating liquidity issues and challenges in sustaining operations without external financing.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	30.16M	58.36M	43.92M	8.86M	889.10K
Gross Profit	15.80M	51.35M	37.59M	2.86M	45.36K
EBITDA	3.20M	2.64M	-4.28M	475.61K	3.58M
Net Income	560.66K	-1.76M	-8.19M	1.74M	-86.82K
Balance Sheet
Total Assets	54.38M	39.54M	21.08M	9.35M	1.51M
Cash, Cash Equivalents and Short-Term Investments	14.37M	9.34M	778.48K	2.56M	220.20K
Total Debt	21.30M	8.92M	12.35M	4.45M	805.51K
Total Liabilities	36.64M	22.10M	26.99M	5.94M	1.25M
Stockholders Equity	17.74M	17.44M	-5.91M	3.41M	258.29K
Cash Flow
Free Cash Flow	-5.44M	-7.85M	-2.76M	1.77M	-428.43K
Operating Cash Flow	-4.28M	-5.91M	-1.45M	2.77M	-46.07K
Investing Cash Flow	-1.13M	-1.94M	-1.59M	-1.23M	-392.10K
Financing Cash Flow	7.62M	16.41M	-202.81K	648.65K	490.97K

AOTI, Inc. Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 27.50
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GB:AOTI, the sentiment is Negative. The current price of 27.5 is below the 20-day moving average (MA) of 37.13, below the 50-day MA of 37.67, and below the 200-day MA of 51.49, indicating a bearish trend. The MACD of -1.14 indicates Positive momentum. The RSI at 34.32 is Neutral, neither overbought nor oversold. The STOCH value of 48.33 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for GB:AOTI.

AOTI, Inc. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
EKF	67 Neutral	£115.24M	15.58	8.71%	―	-1.43%	28.57%
VRCI	58 Neutral	£8.70M	-0.39	-122.54%	―	-57.03%	-15.71%
DXRX	57 Neutral	£123.51M	-5.17	-3.95%	―	31.83%	46.59%
Sector *	55 Neutral	$6.65B	3.83	-15.92%	6.20%	10.91%	7.18%
AOTI	54 Neutral	£36.16M	171.81	3.19%	―	29.20%	78.32%
ABDX	45 Neutral	£19.46M	-7.52	-58.27%	―	37.39%	-126.19%
RENX	40 Underperform	£13.98M	-0.47	425.97%	―	-4.48%	61.09%